Comparison Between the Vibringe and the Conventional Needle
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03551587 |
|
Recruitment Status :
Completed
First Posted : June 11, 2018
Last Update Posted : August 2, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The Vibringe is the first endodontic sonic irrigation system that enables delivery and activation of the irrigation solution in the root canal, in only one step. The activation of the disinfectant by acoustic streaming, enriches and completes the irrigation procedure and improves the success rate of endodontic treatments. It has been shown that this system significantly improves debridement. It also improves the disruption of the smear layer and biofilm by activating irrigation solutions.
As there are no previous studies comparing the Vibringe system with other irrigation techniques under clinical settings, in this regard, the aim of this study is to evaluate whether irrigation with Vibringe provides more or less benefit in terms of postoperative pain when compared with the conventional needle technique.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Endodontic Inflammation | Device: Vibringe | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 18 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Comparative Evaluation Of Postoperative Pain After Using Sonic Vibringe Irrigation System Versus Conventional Irrigation In Single Rooted Teeth With Symptomatic Irreversible Pulpitis : A Randomized Clinical Controlled Trial |
| Actual Study Start Date : | November 28, 2017 |
| Actual Primary Completion Date : | January 27, 2019 |
| Actual Study Completion Date : | February 28, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Irrigant delivered by the Vibringe
Experimental group: The irrigant will be delivered and sonically activated with the Vibringe system. |
Device: Vibringe
The Vibringe is the first endodontic sonic irrigation system that enables delivery and activation of the irrigation solution in the root canal, in only one step. |
|
No Intervention: Irrigation by Conventional needle
Control group: Irrigation procedures will br performed with a conventional method using conventional gauge 24 needle. |
- pain intensity ( post operative pain ) [ Time Frame: 6 hours post- obturation. ]post operative pain measured by Numeric Rating Scale (0-10) where; 0; No pain. 1-3; Mild Pain 4-6; Moderate Pain 7-10; Severe pain: "severe pain, analgesic had no effect in relieving the pain".
- pain intensity ( post operative pain ) [ Time Frame: 12 hours post- obturation. ]post operative pain measured by Numeric Rating Scale (0-10) where; 0; No pain. 1-3; Mild Pain 4-6; Moderate Pain 7-10; Severe pain: "severe pain, analgesic had no effect in relieving the pain".
- pain intensity ( post operative pain ) [ Time Frame: 24 hours post- obturation. ]post operative pain measured by Numeric Rating Scale (0-10) where; 0; No pain. 1-3; Mild Pain 4-6; Moderate Pain 7-10; Severe pain: "severe pain, analgesic had no effect in relieving the pain".
- pain intensity ( post operative pain ) [ Time Frame: 48 hours post- obturation. ]post operative pain measured by Numeric Rating Scale (0-10) where; 0; No pain. 1-3; Mild Pain 4-6; Moderate Pain 7-10; Severe pain: "severe pain, analgesic had no effect in relieving the pain".
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 25 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age between 25-45 years old.
- Males or Females.
- Single rooted teeth with:
- Symptomatic irreversible pulpitis .
- Normal periapical radiographic appearance or slight widening in lamina dura.
Exclusion Criteria:
- Patients on medication for chronic pain.
- Patients having significant systemic disorders.
- Teeth that have :
- Vital pulp tissues.
- Swelling or fistulous tract
- Acute or chronic peri-apical abscess
- Greater than grade I mobility
- Pocket depth greater than 5mm
- No possible restorability
- Previous endodontic treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03551587
| Egypt | |
| Cairo university | |
| Cairo, Egypt | |
| Study Director: | Professor Heba El Far | Cairo University | |
| Study Chair: | Faculty of Dentistry | Cairo University |
| Responsible Party: | Sara shehata, Postgraduate student, Cairo University |
| ClinicalTrials.gov Identifier: | NCT03551587 |
| Other Study ID Numbers: |
Vibringe_Postoperative_pain |
| First Posted: | June 11, 2018 Key Record Dates |
| Last Update Posted: | August 2, 2019 |
| Last Verified: | August 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pulpitis Inflammation Pathologic Processes |
Dental Pulp Diseases Tooth Diseases Stomatognathic Diseases |

